jueves, 31 de octubre de 2019

Insurance, pharma figures spar over impact of Pelosi drug pricing bill

Insurance, pharma figures spar over impact of Pelosi drug pricing bill

The Readout

Damian Garde

More reads

  • New MS drug from Biogen and Alkermes wins approval. (Boston Globe)
  • California wildfires and power outages cause disruptions for scientists. (Nature)
  • Insurance, pharma figures spar over drug price legislation’s innovation impact. (STAT Plus)
  • New details emerge in case of first death from fecal transplant. (STAT)

No hay comentarios: